Table 3.
Summary data for prosthetic studies.
| Study | Resection (cm) | Prosthesis type | N | Age (y) | F-U (m) | Aseptic loosening | Nerve injury | Instability | Infections | Scapular notching | Reinterventions | Failure | MSTS score | Active ROM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Angelini et al. [43] | 11.0 | EndoPT (M) | 33 | 46 | 94 | 2% (1) | 0 | 15% (8) | 4% (2) | — | 35% (19) | 22% (12) | 25 | — |
| Asavamongkolkul et al. [13] | — | EndoPT (CM/M) | 33 | 33 | 81∗ | 3% (2)∗ | 0 | 10% (6)∗ | 3% (2)∗ | — | 20%∗ | 7% (4)∗ | 22.8 | — |
| Cannon et al. [100] | 14 | EndoPT (CM/M) | 83 | 55 | 30 | 0 | 0 | 6% (5) | 2% (2) | — | 1% (1) | 1% (1) | 18.9 | Flex42° Abd41° |
| Fuhrmann et al. [102] | — | EndoPT (M) | 21 | 57 | 47 | 0 | 0 | 0 | 5% (1) | — | 9% (2) | 0% | 18 | — |
| Kiss et al. [42] | — | EndoPT (M) | 36 | 42 | 56∗ | 0 | 6% (2) | 25% (9) | 3% (1) | — | 6% (2) | 6% (2) | 19.7 | — |
| Liu et al. [29] | 11 | EndoPT (CM) | 25 | 30 | 55 | 36% (9) | 0 | 0 | 0 | — | 36% (9) | 36% (9) | 19.1 | — |
| Manfrini et al. [48] | 15.3 | EndoPT (M) | 25 | 10 | 53 | 12% (3) | 0 | 0 | 12% (3) | — | 24% (6) | 16% (4) | 20.9 | — |
| Raiss et al. [41] | 13 | EndoPT (M) | 39 | 60 | 38 | 3% (1) | 0 | 10.2% (4) | 5% (2) | — | 12% (5) | 10% (4) | 19 | Flex34° Abd33° |
| Rödl et al. [28] | 17 | EndoPT (M) | 19 | 37 | 59 | 0 | 0 | 0 | 0 | — | 0 | 0 | 23.6 | — |
| Potter et al. [30] | 13.6 | EndoPT (M) | 16 | 54 | 34 | 0 | 0 | 19% (3) | 0 | — | 25% (4) | 25% (4) | 20.7 | — |
| van de Sande et al. [23] | 9.6 | EndoPT (M) | 14 | 45 | 120∗ | 0 | 0 | 7% (1) | 0 | — | 7% (1) | 7% (1) | 23.1 | — |
| Wei et al. [103] | 20.6 | EndoPT (M) | 20 | 24 | 40 | 10% (2) | 15% (3) | 5% (1) | 0 | — | 5% (1) | 5% (1) | 21.5 | — |
| Bonnevialle et al. [44] | 10.5 | Reverse shoulder (P) | 10 | 55 | 42 | 0 | 10% (1) | 30% (3) | 0 | 30% (3) | 20% (2) | 10% (1) | 20.2 | Flex122° |
| De Wilde et al. [17] | — | Reverse shoulder (P) | 4 | 42 | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27–29 | Flex169° Abd172° |
| De Wilde et al. [104] | — | Reverse shoulder (P) | 14 | 45 | 92 | 1 | 0 | 2 | 1 | 29% (4) | 14% (2) | 14% (2) | — | Abd157° |
| Griffiths et al. [45] | — | Reverse shoulder (P) | 42 | 46 | 71 | 0 | 0 | 26% (14) | 5% (2) | 0 | 9% (4) | 0% | 21.7 | — |
| Guven et al. [46] | 10.2 | Reverse shoulder (P) | 10 | 49 | 18 | 0 | 0 | 20% (2) | 0 | 20% (2) | 20% (2) | 0% | 23.4 | Flex96° Abd88° |
| Hu et al. [105] | 11.8 | Reverse shoulder (P) | 7 | 35 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.7 | Flex133 Abd137 |
| Kaa et al. [49] | 11 | Reverse shoulder (P) | 15 | 42 | 46 | 13% (2) | 0 | 7% (1) | 7% (1) | 0 | 27% (4) | 20% (3) | 23 | Flex98° Abd78° |
| Maclean et al. [106] | 9.3 | Reverse shoulder (P) | 8 | 49 | 43 | 12% (1) | 12% (1) | 0 | 0 | 12% (1) | 0% | 0% | 18 | Flex71° Abd62° |
| Streitbuerger et al. [47] | 15.1 | Reverse shoulder (P) | 18 | 42 | 34 | 0 | 0 | 22% (4) | 6% (1) | 0 | 6% (1) | 6% (1) | 25.1 | Flex84° Abd80° |
N, patients' number; F-U, follow-up. ∗Data referring to the whole population of the study, in which prostheses are only a subpopulation.